SPAC Calendar as of May 17th

Get Alert
05/02/2024CCIX
Churchill Capital Corp IX
05/02/2024$1010/29/2024$250M25.00MGet Alert
05/09/2024GPAT
GP-Act III Acquisition Corp
05/09/2024$1011/05/2024$250M25.00MGet Alert
05/17/2024RFAI
RF ACQUISITION CORP II
05/16/2024$1011/13/2024$100M10.00MGet Alert

Recent SPAC News

MultiMetaVerse To Acquire 100% Of Bowong AI; Amount Determined Based On Further Due Diligence And Negotiation
Norwegian Cruise Line Holdings Announces Its 'Charting the Course' Strategy And 2026 Targets Including Adj. EPS ~$2.45, Adj. Operational EBITDA Margin Of ~39%
Mesa Air shares are trading higher after the company reported Q1 financial results.
Jefferies Initiates Coverage On Steel Dynamics with Hold Rating, Announces Price Target of $150
Jefferies analyst Christopher LeFemina initiates coverage on Steel Dynamics (NASDAQ:STLD) with a Hold rating and announces Price Target of $150.
NETSOL Technologies Q3 EPS $0.03 Down From $0.23 YoY, Sales $15.46M Up From $13.51M YoY
NETSOL Technologies (NASDAQ:NTWK) reported quarterly earnings of $0.03 per share. This is a 86.96 percent decrease over earnings of $0.23 per share from the same period last year. The company reported $15.46 million in
Jefferies Initiates Coverage On Nucor with Hold Rating, Announces Price Target of $190
Jefferies analyst Christopher LeFemina initiates coverage on Nucor (NYSE:NUE) with a Hold rating and announces Price Target of $190.
Scorpius shares are trading higher after the company announced expansion in San Antonio with a new storage and testing facility.
GM Defense And Mistral Announce Collaboration To Enhance Tactical Capability
GM Defense, a subsidiary of General Motors, and Mistral Inc., a provider of high-performance, reliable and innovative solutions to U.S. defense and federal agencies, announced the integration of the innovative
CSL and Arcturus Therapeutics Announce Nature Communications Has Published Pivotal Data Demonstrating Efficacy And Tolerability Of COVID-19 Vaccine
Data follow the approval of the world's first self-amplifying (sa-mRNA) COVID-19 vaccine for adults in Japan. These results add to recently published data on ARCT-154 demonstrating superior immunogenicity to Omicron
Akoustis Technologies shares are trading lower after Qorvo won a jury verdict against the company in a trade secret misappropriation and patent infringement case.